Evotec and Galapagos enter into collaboration in the field of Fibrosis

Collaboration comprises licence agreement for a programme developed by Evotec as well as its drug discovery capabilities Evotec receives undisclosed upfront payment, adn is eligible for potential milestones as well as royalty payments

Topics: Corporate, Drug Discovery, Evotec, Galapagos, Fibrosis, NASH Read More

Evotec receives milestone payment for start of Phase II clinical trial

Evotec's partner, Second Genome, begins a Phase II Clinical trial for NASH with licensed molecule,

Topics: Corporate, Evotec, NASH, Microbiome, Second Genome Read More

Most Read

Posts by Topic